Elite marathoner Peres Jepchirchir faces a provisional suspension following a positive test for erythropoietin (EPO), the blood-doping substance that boosts oxygen-carrying capacity in red blood cells. The Kenyan runner, twice Olympic marathon gold medalist, had her out-of-competition sample collected before her Sydney Marathon victory, according to Runner's World.
Jepchirchir stands among the world's most accomplished distance runners. She claimed gold medals at the Tokyo 2020 and Paris 2024 Olympics, cementing her status as one of the sport's elite performers. Her Sydney Marathon win added another credential to an already decorated resume.
EPO works by stimulating the bone marrow to produce more red blood cells, increasing the blood's oxygen-carrying capacity. Athletes use it to improve endurance performance. The substance is banned by the World Anti-Doping Agency (WADA) and professional athletics governing bodies because it provides an unfair advantage and poses serious health risks, including blood clots, stroke, and heart attack.
Out-of-competition testing occurs outside scheduled race events and is designed to catch athletes who dope during training or recovery phases. These samples carry particular weight in anti-doping cases because they're harder to manipulate and represent the athlete's state during unsupervised periods. The timing of Jepchirchir's sample collection, before her Sydney performance, raises questions about how long the substance remained in her system.
Provisional suspension means Jepchirchir cannot compete while her case proceeds through the formal anti-doping process. She retains the right to contest the finding through testing procedures and administrative hearings. Athletes can request that their B sample be analyzed independently. The full case typically takes months to resolve.
This case hits Kenya's running community hard. Kenyan distance runners dominate global marathons and half-marathons, winning multiple major championships annually. EPO cases involving elite Kenyan athletes remain relatively rare compared to other nations, but they do occur. The country has invested in anti-doping education and testing programs through Athletics Integrity Unit (AIU) oversight.
The provisional suspension affects not only Jepchirchir's immediate competition schedule but also her status for upcoming major marathons and potential future Olympic selection. Every competition cycle she misses during the suspension represents lost earnings, sponsorship opportunities, and ranking points.
WADA's biological passport program can sometimes detect EPO use by measuring red blood cell levels and hemoglobin concentrations over time, even when the substance itself disappears from the bloodstream. Laboratories use sophisticated methods including testosterone/epitestosterone ratios and gene expression profiles to identify EPO use weeks or months after administration.
The athletics world awaits the formal hearing and results of the B sample analysis. Jepchirchir's case underscores that doping enforcement applies equally to medal-winning athletes. The International Athletic Association (now World Athletics) and the AIU have committed to rigorous testing protocols across all levels of professional distance running, particularly among competitors from nations with historically high-performing distance running programs.